PoC Molecular Diagnostics Market: By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based and Microarray-based), By Test Location (OTC and POC), By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology and Other Applications), By End User (Decentralized Labs, Hospitals, Home-care, Assisted Living Healthcare Facilities and Other users) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

PoC Molecular Diagnostics Market size was valued at USD 2.50 billion in 2022 and is expected to reach USD 3.9 billion by 2029, at a CAGR of 11.69% from 2023-2029. Rising focus on decentralized diagnostics, increasing worldwide prevalence of infectious diseases, improved need for accurate and faster testing methods, growing awareness regarding benefits of early disease diagnosis and awareness amongst people will increase demand for point of care molecular diagnostics and growing demand for CLIA-waived molecular POC tests are some key factors fostering the market growth. However, factors such as Inadequate Reimbursements and strict government regulations are hindering the market growth. This report studies global PoC molecular diagnostics market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Global Poc Molecular Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

11.69%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America
PoC Molecular Diagnostics Market Dynamics

Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system. Many tests have received clinical laboratory improvement amendments (CLIA) waivers that enable POC use. CLIA-waived tests are typically simple and have a low risk for an incorrect result. With CLIA waiver, these tests can be used in a wide range of settings including pharmacy-based clinics, urgent care centers and hospitals, increasing access to testing and streamlining care. Another feature of many POC molecular flu tests is room temperature storage of test components, creating a more versatile lab footprint and allowing testing to be performed in a variety of locations.

Key Features of the Reports

  • The PoC molecular diagnostics market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Poc Molecular Diagnostics Market Segmentation

By Technology
  • PCR-based
  • Genetic Sequencing-based
  • Hybridization-based
  • Microarray-based
By Test Location
  • OTC
  • POC
By Application
By End User
  • Decentralized Labs
  • Hospitals
  • Home-care
  • Assisted Living Healthcare Facilities
  • Other users

Frequently Asked Questions

The poc molecular diagnostics market is projected to expand at a CAGR of 11.69% during the forecast period

Abbott Laboratories, Danaher Corporation, Biomérieux Sa, Roche Diagnostics, Quidel, Meridian Bioscience, Mesa Biotech, Genepoc, DxNA, Atlas Genetics, Spartan Bioscience

North America is the fastest-growing region for poc molecular diagnostics market

1. Executive Summary
2. Global PoC Molecular Diagnostics Market Introduction 
2.1.Global PoC Molecular Diagnostics Market  - Taxonomy
2.2.Global PoC Molecular Diagnostics Market  - Definitions
2.2.1.Technology
2.2.2.Test Location
2.2.3.Application
2.2.4.End User
2.2.5.Region
3. Global PoC Molecular Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global PoC Molecular Diagnostics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global PoC Molecular Diagnostics Market  By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. PCR-based
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Genetic Sequencing-based
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Hybridization-based
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Microarray-based
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global PoC Molecular Diagnostics Market  By Test Location, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. OTC
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. POC
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global PoC Molecular Diagnostics Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Infectious Diseases
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Oncology
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Hematology
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Prenatal Testing
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Endocrinology
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Other Applications
7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
8. Global PoC Molecular Diagnostics Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Decentralized Labs
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Hospitals
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Home-care
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Assisted Living Healthcare Facilities
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Other users
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. Global PoC Molecular Diagnostics Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.PCR-based
10.1.2.Genetic Sequencing-based
10.1.3.Hybridization-based
10.1.4.Microarray-based
10.2.  Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.OTC
10.2.2.POC
10.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Infectious Diseases
10.3.2.Oncology
10.3.3.Hematology
10.3.4.Prenatal Testing
10.3.5.Endocrinology
10.3.6.Other Applications
10.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Decentralized Labs
10.4.2.Hospitals
10.4.3.Home-care
10.4.4.Assisted Living Healthcare Facilities
10.4.5.Other users
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.PCR-based
11.1.2.Genetic Sequencing-based
11.1.3.Hybridization-based
11.1.4.Microarray-based
11.2.  Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.OTC
11.2.2.POC
11.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Infectious Diseases
11.3.2.Oncology
11.3.3.Hematology
11.3.4.Prenatal Testing
11.3.5.Endocrinology
11.3.6.Other Applications
11.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Decentralized Labs
11.4.2.Hospitals
11.4.3.Home-care
11.4.4.Assisted Living Healthcare Facilities
11.4.5.Other users
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.PCR-based
12.1.2.Genetic Sequencing-based
12.1.3.Hybridization-based
12.1.4.Microarray-based
12.2.  Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.OTC
12.2.2.POC
12.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Infectious Diseases
12.3.2.Oncology
12.3.3.Hematology
12.3.4.Prenatal Testing
12.3.5.Endocrinology
12.3.6.Other Applications
12.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Decentralized Labs
12.4.2.Hospitals
12.4.3.Home-care
12.4.4.Assisted Living Healthcare Facilities
12.4.5.Other users
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.PCR-based
13.1.2.Genetic Sequencing-based
13.1.3.Hybridization-based
13.1.4.Microarray-based
13.2.  Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.OTC
13.2.2.POC
13.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Infectious Diseases
13.3.2.Oncology
13.3.3.Hematology
13.3.4.Prenatal Testing
13.3.5.Endocrinology
13.3.6.Other Applications
13.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Decentralized Labs
13.4.2.Hospitals
13.4.3.Home-care
13.4.4.Assisted Living Healthcare Facilities
13.4.5.Other users
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America PoC Molecular Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.PCR-based
14.1.2.Genetic Sequencing-based
14.1.3.Hybridization-based
14.1.4.Microarray-based
14.2.  Test Location Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.OTC
14.2.2.POC
14.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Infectious Diseases
14.3.2.Oncology
14.3.3.Hematology
14.3.4.Prenatal Testing
14.3.5.Endocrinology
14.3.6.Other Applications
14.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Decentralized Labs
14.4.2.Hospitals
14.4.3.Home-care
14.4.4.Assisted Living Healthcare Facilities
14.4.5.Other users
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1. Abbott Laboratories
15.2.2. Danaher Corporation
15.2.3. Biomerieux Sa
15.2.4. Roche Diagnostics
15.2.5. Quidel
15.2.6. Meridian Bioscience
15.2.7. Mesa Biotech
15.2.8. Genepoc
15.2.9. DxNA
15.2.10. Atlas Genetics
15.2.11. Spartan Bioscience
15.2.12. Biocartis
16. Research Methodology 
17. Appendix and Abbreviations 
  • Abbott Laboratories
  • Danaher Corporation
  • Biomerieux Sa
  • Roche Diagnostics
  • Quidel
  • Meridian Bioscience
  • Mesa Biotech
  • Genepoc
  • DxNA
  • Atlas Genetics
  • Spartan Bioscience
  • Biocartis